Peter Ström

Human herpesvirus 7 and the risk of developing multiple sclerosis

Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis

Interactions between High Seroreactivity to Human Herpes Virus <scp>6A</scp> and Epstein–Barr Virus in <scp>MS</scp> Development: A Presymptomatic Case–Control Study

Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis

Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis

Surgery with locking plate or hemiarthroplasty versus nonoperative treatment of 3–4-part proximal humerus fractures in older patients (NITEP): An open-label randomized trial

The human bone marrow plasma cell compartment in rheumatoid arthritis - Clonal relationships and anti-citrulline autoantibody producing cells

Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis

Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis

Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

Different Hierarchies of Anti–Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis

Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

Operative versus non-operative treatment for 2-part proximal humerus fracture: A multicenter randomized controlled trial

Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis

Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis

Increased serological response against human herpesvirus 6A is associated with risk for multiple sclerosis

Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell–Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis

Pathogenic Citrulline‐Multispecific B Cell Receptor Clades in Rheumatoid Arthritis

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study